These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 22476850)

  • 21. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment.
    Bufi E; Belli P; Di Matteo M; Terribile D; Franceschini G; Nardone L; Petrone G; Bonomo L
    Eur J Radiol; 2014 Sep; 83(9):1631-8. PubMed ID: 24938669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results.
    Loo CE; Teertstra HJ; Rodenhuis S; van de Vijver MJ; Hannemann J; Muller SH; Peeters MJ; Gilhuijs KG
    AJR Am J Roentgenol; 2008 Nov; 191(5):1331-8. PubMed ID: 18941065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
    Choi BB; Kim SH
    Acta Radiol; 2015 Jul; 56(7):790-7. PubMed ID: 24951616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis.
    Heldahl MG; Bathen TF; Rydland J; Kvistad KA; Lundgren S; Gribbestad IS; Goa PE
    Acta Radiol; 2010 Jul; 51(6):604-12. PubMed ID: 20429756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy.
    Liu S; Ren R; Chen Z; Wang Y; Fan T; Li C; Zhang P
    J Magn Reson Imaging; 2015 Sep; 42(3):779-87. PubMed ID: 25580585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic breast magnetic resonance imaging: pretreatment prediction of tumor response to neoadjuvant chemotherapy.
    Dongfeng H; Daqing M; Erhu J
    Clin Breast Cancer; 2012 Apr; 12(2):94-101. PubMed ID: 22169574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of dynamic contrast-enhanced MRI in assessment of early response to neoadjuvant chemotherapy in breast cancer].
    Wang XH; Peng WJ; Xin C; Tan HN; Gu YJ; Tang F; Mao J
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):539-43. PubMed ID: 21029700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
    Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
    NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contribution of MRI for monitoring response to neoadjuvant chemotherapy in the management of breast cancer].
    Fellah L; Berlière M; Galant C; Akle N; Leconte I
    JBR-BTR; 2009; 92(4):224-6. PubMed ID: 19803103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of diffusion-weighted imaging for the discrimination of pancreatic lesions: a meta-analysis.
    Wu LM; Xu JR; Hua J; Gu HY; Zhang XF; Lu Q; Hu JN
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):134-42. PubMed ID: 22241215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer.
    Purkayastha S; Tekkis PP; Athanasiou T; Tilney HS; Darzi AW; Heriot AG
    Colorectal Dis; 2007 Jun; 9(5):402-11. PubMed ID: 17504336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-weighted MRI as an adjunct to mammography in women under 50 years of age: an initial study.
    Kazama T; Kuroki Y; Kikuchi M; Sato Y; Nagashima T; Miyazawa Y; Sakakibara M; Kaneoya K; Makimoto Y; Hashimoto H; Motoori K; Takano H
    J Magn Reson Imaging; 2012 Jul; 36(1):139-44. PubMed ID: 22359367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment.
    Belli P; Costantini M; Ierardi C; Bufi E; Amato D; Mule' A; Nardone L; Terribile D; Bonomo L
    Breast J; 2011; 17(6):610-9. PubMed ID: 21929557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.
    Bufi E; Belli P; Costantini M; Cipriani A; Di Matteo M; Bonatesta A; Franceschini G; Terribile D; Mulé A; Nardone L; Bonomo L
    Clin Breast Cancer; 2015 Oct; 15(5):370-80. PubMed ID: 25891905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
    Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
    J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
    Giannarini G; Petralia G; Thoeny HC
    Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted imaging in monitoring the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis.
    Gao W; Guo N; Dong T
    World J Surg Oncol; 2018 Jul; 16(1):145. PubMed ID: 30021656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.